Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SLC13A5-IN-1 is a selective inhibitor of sodium-citrate co-transporter (SLC13A5),completely blocks the uptake of 14C-citrate(IC50 : 0.022 μM in HepG2 cells).
ターゲット&IC50 | HepG2/14C-Citrate uptake:0.022 μM , Recombinant hSLC3A5/14C-Citrate Uptake:0.056 μM |
分子量 | 461.79 |
分子式 | C19H19Cl3N2O3S |
CAS No. | 2227548-95-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/ml (10.83 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SLC13A5-IN-1 2227548-95-8 Metabolism Stearoyl-CoA Desaturase (SCD) hSLC3A5 metabolic SLC-13A5-IN-1 SLC13A5IN1 Inhibitor Citrate SLC13A5 cardiovascular inhibit disease Sodium Channel Uptake Na channels Na+ channels SLC13A5 IN 1 inhibitor